OBJECTIVE: Genetic variants that contribute to the risk of psychiatric disorders may also affect normal variation in psychological function. Indeed, the behavioral effects of many genetic variants may be better understood as process-specific rather than disease-specific. A functional valine-to-methionine (Val(158)Met) polymorphism in the catechol-O-methyltransferase (COMT) gene has been associated with cognitive function and brain metabolic activity accompanying such tasks. Not all studies are consistent, and less is known about the effect of this polymorphism during development. The authors tested the hypothesis that a more informative COMT haplotype predicts normal cognitive development in a large population-based cohort of children enrolled in the Avon Longitudinal Study of Parents and Children. METHOD: Effects on verbal and performance IQ as well as verbal inhibition were assessed at age 8, and effects on working memory were assessed at age 10. From the five COMT single nucleotide polymorphisms (SNPs) genotyped, the effect of a functional three-SNP haplotype consisting of Val(158)Met and two synonymous SNPs (rs6269 and rs4818), which together exert a major influence on the level of COMT expression and enzyme activity, was evaluated. RESULTS: This three-SNP haplotype predicted both verbal inhibition and working memory, and there was a genotype-by-sex interaction on verbal IQ. The effect of COMT genotype (diplotype) on cognition was curvilinear, which is consistent with the "inverted U" model of dopamine effect on frontal cortical efficiency. In addition, the SNP rs2075507 (previously rs2097603) was independently associated with verbal inhibition, while rs165599 showed no main cognitive effects. However, rs165599 showed a genotype-by-sex interaction with working memory. CONCLUSIONS: Genetic variation at several loci in the COMT gene affects normal cognitive function in children.
OBJECTIVE: Genetic variants that contribute to the risk of psychiatric disorders may also affect normal variation in psychological function. Indeed, the behavioral effects of many genetic variants may be better understood as process-specific rather than disease-specific. A functional valine-to-methionine (Val(158)Met) polymorphism in the catechol-O-methyltransferase (COMT) gene has been associated with cognitive function and brain metabolic activity accompanying such tasks. Not all studies are consistent, and less is known about the effect of this polymorphism during development. The authors tested the hypothesis that a more informative COMT haplotype predicts normal cognitive development in a large population-based cohort of children enrolled in the Avon Longitudinal Study of Parents and Children. METHOD: Effects on verbal and performance IQ as well as verbal inhibition were assessed at age 8, and effects on working memory were assessed at age 10. From the five COMT single nucleotide polymorphisms (SNPs) genotyped, the effect of a functional three-SNP haplotype consisting of Val(158)Met and two synonymous SNPs (rs6269 and rs4818), which together exert a major influence on the level of COMT expression and enzyme activity, was evaluated. RESULTS: This three-SNP haplotype predicted both verbal inhibition and working memory, and there was a genotype-by-sex interaction on verbal IQ. The effect of COMT genotype (diplotype) on cognition was curvilinear, which is consistent with the "inverted U" model of dopamine effect on frontal cortical efficiency. In addition, the SNP rs2075507 (previously rs2097603) was independently associated with verbal inhibition, while rs165599 showed no main cognitive effects. However, rs165599 showed a genotype-by-sex interaction with working memory. CONCLUSIONS: Genetic variation at several loci in the COMT gene affects normal cognitive function in children.
Authors: Raymond C K Chan; Ronald Y L Chen; Eric Y H Chen; Tomy C K Hui; Eric F C Cheung; H K Cheung; Pak Sham; Tao Li; David Collier Journal: J Int Neuropsychol Soc Date: 2005-03 Impact factor: 2.892
Authors: S Shifman; A Bhomra; S Smiley; N R Wray; M R James; N G Martin; J M Hettema; S S An; M C Neale; E J C G van den Oord; K S Kendler; X Chen; D I Boomsma; C M Middeldorp; J J Hottenga; P E Slagboom; J Flint Journal: Mol Psychiatry Date: 2007-07-31 Impact factor: 15.992
Authors: E M Tunbridge; C S Weickert; J E Kleinman; M M Herman; J Chen; B S Kolachana; P J Harrison; D R Weinberger Journal: Cereb Cortex Date: 2006-07-11 Impact factor: 5.357
Authors: A G Nackley; S A Shabalina; I E Tchivileva; K Satterfield; O Korchynskyi; S S Makarov; W Maixner; L Diatchenko Journal: Science Date: 2006-12-22 Impact factor: 47.728
Authors: Leonid Yavich; Markus M Forsberg; Maria Karayiorgou; Joseph A Gogos; Pekka T Männistö Journal: J Neurosci Date: 2007-09-19 Impact factor: 6.167
Authors: Zoe H Brett; Margaret Sheridan; Kate Humphreys; Anna Smyke; Mary Margaret Gleason; Nathan Fox; Charles Zeanah; Charles Nelson; Stacy Drury Journal: Int J Behav Dev Date: 2015-03
Authors: Vandana Shashi; Timothy D Howard; Matcheri S Keshavan; Jessica Kaczorowski; Margaret N Berry; Kelly Schoch; Edward J Spence; Thomas R Kwapil Journal: Psychiatry Res Date: 2010-05-20 Impact factor: 3.222
Authors: Rosalind J Miller; Kim G Jackson; Tony Dadd; Beate Nicol; Joanne L Dick; Andrew E Mayes; A Louise Brown; Anne M Minihane Journal: Eur J Nutr Date: 2011-03-29 Impact factor: 5.614
Authors: Clancy Blair; Michael Sulik; Michael Willoughby; Roger Mills-Koonce; Stephen Petrill; Christopher Bartlett; Mark Greenberg Journal: Dev Psychobiol Date: 2015-08-06 Impact factor: 3.038
Authors: James S Woods; Nicholas J Heyer; Joan E Russo; Michael D Martin; Federico M Farin Journal: Neurotoxicology Date: 2014-08-07 Impact factor: 4.294